Cognitive Impairment

Cognitive Impairment

Contact hours
3.00
On Demand

Among adults, cognitive impairment has been reported in up to 80% of patients with brain tumors, 70%–80% of patients with lung cancer, and 40% of patients with acute myeloid leukemia. It has also been reported in up to 75% of patients with breast cancer and in patients treated with bone marrow transplantation after high-dose chemotherapy. In addition, childhood cancer survivors may have long-term changes in cognitive function. Make sure you have the skills needed to address this common side effect, which can be exceptionally challenging for patients as well as their loved ones. 

This course is included in the Hormonal Therapy Symptom Management Bundle and is offered on demand. Instructions on how to immediately access the course will be sent to you in an automatically generated email receipt after you register. You will enjoy continuous access for six months.

Cognitive Impairment Course Topics

  • Cognitive Function
  • Cognitive Impairment
  • Cancer-Related Cognitive Impairment: Pathophysiology, Risk Factors, and Assessment
  • Cancer-Related Cognitive Impairment: Coping Strategies and Interventions
  • Delirium: Pathophysiology, Risk Factors, Assessment, and Interventions

You may also be interested in the ONS books A Guide to Oncology Symptom Management and Putting Evidence Into Practice: A Pocket Guide to Cancer Symptom Management.

Don't want to choose between courses? This course is included in the Hormonal Therapy Symptom Management Bundle. Save when you purchase the bundle or you may also register for a course individually.
 

Hormonal Therapy Symptom Management Bundle

Expected Outcome

Upon completion of this activity, the learner will demonstrate knowledge of the assessment and management of cognitive impairment in patients with cancer by passing the post-test with score of ≥ 80%.

Target Audience

This course is intended for nurses desiring to learn more about symptom management in patients with cancer.

ILNA Breakdown

OCN®, CBCN®, AOCNP®, AOCNS®, and CPHON®
3 ILNA points may be applied toward:

  • 3 points: Psychosocial or Survivorship

BMTCN™
3 ILNA points may be applied toward:

    3 points: Survivorship or Post Transplant Issues
Learning Objectives
  • Define patients at risk for cognitive impairment.
  • Describe indicators used in the assessment of cognitive impairment.
  • Identify interventions utilized in the management of cognitive impairment.
  • Select appropriate evidence-based interventions for the care of an individual at risk for or experiencing cognitive impairment.

The Oncology Nursing Society is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's (ANCC) Commission on Accreditation.

ONS is approved as a provider of continuing education by the California Board of Registered Nursing, Provider #2850.

Individual Pricing Options

$40.00
Member
$90.00
Nonmember

Group purchases are available

 Registering for 10 or more people? Group discounts are available for this course.

To find out more, contact ONS customer service at help@ons.org or 866-257-4667, option 2. Our office hours are Monday through Friday from 8:30 am–5 pm EST.

How to Sign Up
1 Log In
2 Review Policies

Menu